Clinical analysis and pluripotent stem cells-based model reveal possible impacts of ACE2 and lung progenitor cells on infants vulnerable to COVID-19

Zhao Zhang(Nanjing Normal University), Qizhou Lian(Chinese Academy of Sciences), Ruibang Luo(University of Hong Kong), Jinqiu Zhang(Jiangsu Academy of Agricultural Sciences), Yanheng Wu(The University of Queensland), Huanhuan Joyce Chen(University of Chicago), Che Zhang(Hubei University of Medicine), Hua Jiang(Renji Hospital), Fuyu Duan(Tsinghua University), Jianbo Shao(Southern University of Science and Technology), Peikai Chen(Chinese University of Hong Kong), Hung‐Fat Tse(University of Hong Kong), Yi Xu(Guangzhou Women and Children Medical Center), Huiying Liang(Aga Khan University), Xiaoxia Lü(Sun Yat-sen University), Cheng Li(University of Science and Technology of China), Li Liu(Hangzhou Hospital of Traditional Chinese Medicine), Hui Li(Shanghai Stomatological Hospital), Wei Liu(St. Jude Children's Research Hospital), Zhiwei Chen(Fujian Medical University), Le Li(World Health Organization - Pakistan), Ting Zhang(Fuyang City People's Hospital), Xianfeng Wang(Tulane University), Junhui Chen(Henan University of Traditional Chinese Medicine), Li Huang(Soochow University), Huimin Xia(Guangzhou Women and Children Medical Center), Hui Du(Wuhan Children's Hospital), Can Liao(Guangzhou Women and Children Medical Center), Guangyin Yu(Peking University Shenzhen Hospital), Liang Zeng(Guangzhou Medical University), Ka Yi Kwan(University of Hong Kong), Chui Yan(Guangzhou Medical University), Liyan Guo(Sichuan University), Xiaoqiong Gu(Guangzhou Women and Children Medical Center)
Theranostics
December 16, 2020
Cited by 23


Related Papers